Cytosorbents (CTSO) Cash from Investing Activities (2010 - 2026)
Cytosorbents' (CTSO) quarterly Cash from Investing Activities came in at -$46000.0 in Q1 2026, up 2.13% YoY from -$45041.7 in Q1 2025, and up 84.19% on a QoQ basis from -$291000.0 in Q4 2025.
Cytosorbents (CTSO) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Cash from Investing Activities data on file, last reported at -$46000.0 in Q1 2026.
- Quarterly Cash from Investing Activities rose 2.13% year-over-year to -$46000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$414000.0 (up 29.71% YoY) and the FY2025 annual result came in at -$415000.0, up 37.97% from the prior year.
- Cash from Investing Activities climbed to -$46000.0 in Q1 2026, from -$291000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $140285.0 in Q2 2023 to a low of -$4.7 million in Q2 2022.
- A 5-year average of -$501283.1 and a median of -$135922.0 in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 375.79% — and 2025, when it jumped 118.39%.
- Tracing CTSO's Cash from Investing Activities over 5 years: stood at -$206080.0 in 2022, then surged by 34.04% to -$135922.0 in 2023, then increased by 8.77% to -$124000.0 in 2024, then tumbled by 134.68% to -$291000.0 in 2025, then jumped by 84.19% to -$46000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$46000.0 (Q1 2026), -$291000.0 (Q4 2025), and $55000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,000.00 |
| Jun 30, 2026 | 7,000.00 |
| Mar 31, 2026 | -46,000.00 |
| Mar 31, 2026 | -46,000.00 |
| Dec 31, 2025 | -291,000.00 |
| Dec 31, 2025 | -291,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Mar 31, 2025 | -47,000.00 |
| Mar 31, 2025 | -47,000.00 |
| Dec 31, 2024 | -124,000.00 |
| Dec 31, 2024 | -124,000.00 |
| Sep 30, 2024 | -299,000.00 |
| Sep 30, 2024 | -299,000.00 |
| Jun 30, 2024 | -118,982.00 |
| Jun 30, 2024 | -118,982.00 |
| Mar 31, 2024 | -127,018.00 |
| Mar 31, 2024 | -127,018.00 |